National Vision Holdings, Inc.

EYE ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017
Operating Activities
Net Income $29.6M $-28.5M $-65.9M $42.1M $36.3M $32.8M $23.7M $43.1M
Depreciation & Amortization $91.2M $91.3M $89.9M $88.7M $91.6M $87.2M $74.3M $62.0M
Depreciation — — — — — — — $52.7M
Amortization $700.0K $1.4M $1.6M $1.5M — — — $8.4M
Stock-Based Compensation $23.7M $16.7M $20.2M $13.5M $10.7M $12.7M $20.9M $5.2M
Net Cash from Operating Activities $146.3M $133.6M $173.0M $119.2M $235.0M $165.1M $106.6M $90.3M
Investing Activities
Capital Expenditures $72.8M $95.5M $114.8M $113.5M $76.8M $101.3M $104.5M $93.2M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-76.6M $-96.1M $-115.8M $-110.9M $-76.4M $-100.6M $-104.2M $-94.6M
Financing Activities
Dividends Paid — — — — — $0 $0 $171.0M
Stock Repurchases $3.2M $3.1M $28.4M $84.4M $689.0K $25.6M $1.9M $0
Net Cash from Financing Activities $-104.6M $-113.3M $-136.8M $-84.6M $176.3M $-42.1M $10.4M $3.8M
Net Change in Cash $-34.9M $-75.8M $-79.6M $-76.3M $334.9M $22.3M $12.8M —
Free Cash Flow $73.5M $38.1M $58.3M $5.7M $158.2M $63.8M $2.1M $-3.0M
← Newer Page 1 of 2 Older →